CXHL1200134 | 罗氟司特片 | roflumilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2012-07-18 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2014-10-10 | view |
CXHL1200132 | 罗氟司特 | roflumilast | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2012-07-18 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2014-10-10 | view |
CXHL1301132 | 醋酸阿比特龙片 | abiraterone acetate | Tablet | Chemical Drugs(3.1) | New Drug Application | 2013-12-25 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2015-09-16 | view |
CXHL1301131 | 醋酸阿比特龙 | abiraterone acetate | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2013-12-25 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2015-09-23 | view |
CXHL1300155 | 阿齐沙坦片 | azilsartan | Tablet | Chemical Drugs(3.1) | New Drug Application | 2013-04-26 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2015-12-30 | view |
CXHL1300153 | 阿齐沙坦 | azilsartan | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2013-04-26 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2015-12-30 | view |
CXHL1300154 | 阿齐沙坦片 | azilsartan | Tablet | Chemical Drugs(3.1) | New Drug Application | 2013-04-26 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2015-12-30 | view |
CXHL1400371 | 卡巴他赛注射液 | cabazitaxel | Injection | Chemical Drugs(3.1) | New Drug Application | 2014-04-24 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2016-02-19 | view |
CXHL1400370 | 卡巴他赛 | cabazitaxel | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2014-04-24 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2016-02-19 | view |
CXHL1400092 | 甲苯磺酸依度沙班片 | Edoxaban Tosilate | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-04-24 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2016-02-19 | view |
CXHL1400090 | 甲苯磺酸依度沙班 | Edoxaban Tosilate | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2014-04-24 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2016-02-29 | view |
CXHL1400626 | 枸橼酸托法替布片 | tofacitinib citrate | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-07-16 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2016-03-01 | view |
CXHL1400091 | 甲苯磺酸依度沙班片 | Edoxaban Tosilate | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-04-24 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2016-03-10 | view |
CXHL1400625 | 枸橼酸托法替布 | tofacitinib citrate | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2014-07-16 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2016-03-11 | view |
CXHL1401402 | 达格列净 | dapagliflozin | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2014-10-16 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2016-03-25 | view |
CXHL1401403 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-10-16 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2016-03-25 | view |
CXHL1401404 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-10-16 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2016-03-25 | view |
CXHL1500047 | 阿普斯特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-05 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2016-05-11 | view |
CXHL1500046 | 阿普斯特片 | apremilast | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-05 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2016-05-11 | view |
CXHL1401320 | 复合葡萄糖酸钠铁 | | Active ingredient | Chemical Drugs(3.1) | New Drug Application | 2014-10-16 | 石家庄智恒医药科技有限公司 | Hebei Zhiheng Pharmaceutical Co Ltd | Certificate Issued | 2016-05-19 | view |